<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>269-HYDROXYCHLOROQUINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="HYDROXYCHLOROQUINE" rxcui="5521">
<ATC code="P01BA02" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="METOPROLOL" rxcui="6918">
<ATC code="C07AB02" />
<ATC code="C07FB02" />
<ATC code="C07CB02" />
<ATC code="C07BB02" />
</DRUG>
</DRUG2>
<DESCRIPTION>With the metoprolol used in heart failure: risk of increase of the undesirable effects of metoprolol due to decrease of its hepatic metabolism by the hydroxycloroquine</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>269-HYDROXYCHLOROQUINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="HYDROXYCHLOROQUINE" rxcui="5521">
<ATC code="P01BA02" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="RIFAMPICIN" rxcui="9384">
<ATC code="J04AB02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of decrease of the therapeutic effect of the hydroxychloroquine, due to increase of its metabolism by the rifampicin</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>269-HYDROXYCHLOROQUINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="HYDROXYCHLOROQUINE" rxcui="5521">
<ATC code="P01BA02" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES" code="C01-N05" /></DRUG2>
<DESCRIPTION>Increased risk of ventricular arrhythmias, especially of torsades de pointes </DESCRIPTION>
<SEVERITY>Contraindication</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
</INTERACTIONS>
